Cargando…
Novel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment
There is growing evidence that the imbalance between oxidative stress and the antioxidant defense system may be associated with the development neuropsychiatric disorders, such as depression and anxiety. Major depression and anxiety are presently correlated with a lowered total antioxidant state and...
Autores principales: | Xu, Ying, Wang, Chuang, Klabnik, Jonathan J, O’Donnell, James M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964743/ https://www.ncbi.nlm.nih.gov/pubmed/24669206 http://dx.doi.org/10.2174/1570159X11666131120231448 |
Ejemplares similares
-
The Impact of Peplau's Therapeutic Communication Model on Anxiety and Depression in Patients Candidate for Coronary Artery Bypass
por: Zarea, Kourosh, et al.
Publicado: (2014) -
Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders
por: Pérez de la Mora, Miguel, et al.
Publicado: (2022) -
NLRP3-Dependent Pyroptosis: A Candidate Therapeutic Target for Depression
por: Wan, Teng, et al.
Publicado: (2022) -
Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB
por: Millard, James, et al.
Publicado: (2023) -
Role of antioxidants in generalised anxiety disorder and depression
por: Gautam, Medhavi, et al.
Publicado: (2012)